PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NVO vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


NVOXLV
YTD Return32.18%6.28%
1Y Return68.93%14.87%
3Y Return (Ann)51.66%6.84%
5Y Return (Ann)42.88%11.95%
10Y Return (Ann)21.98%11.10%
Sharpe Ratio2.181.30
Daily Std Dev31.94%10.54%
Max Drawdown-51.38%-39.18%
Current Drawdown0.00%-2.24%

Correlation

-0.50.00.51.00.4

The correlation between NVO and XLV is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

NVO vs. XLV - Performance Comparison

In the year-to-date period, NVO achieves a 32.18% return, which is significantly higher than XLV's 6.28% return. Over the past 10 years, NVO has outperformed XLV with an annualized return of 21.98%, while XLV has yielded a comparatively lower 11.10% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%5,000.00%10,000.00%15,000.00%December2024FebruaryMarchAprilMay
16,270.64%
731.61%
NVO
XLV

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Novo Nordisk A/S

Health Care Select Sector SPDR Fund

Risk-Adjusted Performance

NVO vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NVO
Sharpe ratio
The chart of Sharpe ratio for NVO, currently valued at 2.18, compared to the broader market-2.00-1.000.001.002.003.004.002.18
Sortino ratio
The chart of Sortino ratio for NVO, currently valued at 3.63, compared to the broader market-4.00-2.000.002.004.006.003.63
Omega ratio
The chart of Omega ratio for NVO, currently valued at 1.42, compared to the broader market0.501.001.502.001.42
Calmar ratio
The chart of Calmar ratio for NVO, currently valued at 5.79, compared to the broader market0.002.004.006.005.79
Martin ratio
The chart of Martin ratio for NVO, currently valued at 16.03, compared to the broader market-10.000.0010.0020.0030.0016.03
XLV
Sharpe ratio
The chart of Sharpe ratio for XLV, currently valued at 1.30, compared to the broader market-2.00-1.000.001.002.003.004.001.30
Sortino ratio
The chart of Sortino ratio for XLV, currently valued at 1.90, compared to the broader market-4.00-2.000.002.004.006.001.90
Omega ratio
The chart of Omega ratio for XLV, currently valued at 1.23, compared to the broader market0.501.001.502.001.23
Calmar ratio
The chart of Calmar ratio for XLV, currently valued at 1.17, compared to the broader market0.002.004.006.001.17
Martin ratio
The chart of Martin ratio for XLV, currently valued at 4.36, compared to the broader market-10.000.0010.0020.0030.004.36

NVO vs. XLV - Sharpe Ratio Comparison

The current NVO Sharpe Ratio is 2.18, which is higher than the XLV Sharpe Ratio of 1.30. The chart below compares the 12-month rolling Sharpe Ratio of NVO and XLV.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00December2024FebruaryMarchAprilMay
2.18
1.30
NVO
XLV

Dividends

NVO vs. XLV - Dividend Comparison

NVO's dividend yield for the trailing twelve months is around 0.72%, less than XLV's 1.53% yield.


TTM20232022202120202019201820172016201520142013
NVO
Novo Nordisk A/S
0.72%0.71%0.84%0.94%1.33%1.51%1.97%1.52%2.87%0.92%1.43%1.23%
XLV
Health Care Select Sector SPDR Fund
1.53%1.59%1.47%1.33%1.49%2.16%1.56%1.46%1.59%1.43%1.34%1.51%

Drawdowns

NVO vs. XLV - Drawdown Comparison

The maximum NVO drawdown since its inception was -51.38%, which is greater than XLV's maximum drawdown of -39.18%. Use the drawdown chart below to compare losses from any high point for NVO and XLV. For additional features, visit the drawdowns tool.


-10.00%-8.00%-6.00%-4.00%-2.00%0.00%December2024FebruaryMarchAprilMay0
-2.24%
NVO
XLV

Volatility

NVO vs. XLV - Volatility Comparison

Novo Nordisk A/S (NVO) has a higher volatility of 6.85% compared to Health Care Select Sector SPDR Fund (XLV) at 2.36%. This indicates that NVO's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%December2024FebruaryMarchAprilMay
6.85%
2.36%
NVO
XLV